Pressure ulcer prevalence, use of preventive measures, and mortality risk in an acute care population: a quality improvement project.
The primary aim of this quality improvement project was to determine pressure prevalence, risk of mortality, and use of preventive measures in a group of hospitalized patients. Two hundred fifty-eight patients recruited from Skaraborg Hospital in Sweden were assessed. A 1-day point prevalence study was carried out using a protocol advocated by the European PU Advisory Panel. Patients' age, gender, severity of PU (grades I-IV), anatomical location of PU, and use of preventive measures were recorded. The Swedish language version of the Modified Norton Scale was used for PU risk assessment. Data were collected by nurses trained according to the Web-based training: PU classification, "ePuclas2." After 21 months, a retrospective audit of the electronic records for patients identified with pressure ulcers was completed. The point prevalence of pressure ulcers was 23%. The total number of ulcers was 85, most were grade 1 (n = 39). The most common locations were the sacrum (n = 15) and the heel (n = 10). Three percent of patients (n = 9) had been assessed during their current hospital stay using a risk assessment tool. There was a statistically significant relationship between pressure ulcer occurrence and a low total score on the Modified Norton Scale. The patients' ages correlated significantly to the presence of a pressure ulcer. Patients with a pressure ulcer had a 3.6-fold increased risk of dying within 21 months, as compared with those without a pressure ulcer. Based on results from this quality improvement project, we recommend routine pressure ulcer risk assessment for all patients managed in a hospital setting such as ours. We further recommend that particular attention should be given to older and frail patients who are at higher risk for pressure ulcer occurrence and mortality.
Siv Leijon, MSc, RN, Wound Nurse, Department of Dermatology, Kärnsjukhuset, Skövde Hospital, Sweden. Ingrid Bergh, PhD, RN, Professor, Nursing Science, School of Life Sciences, University of Skövde, Sweden. Karin Terstappen, MD, PhD, Chief Physician, Department of Dermatology, Kärnsjukhuset, Skövde Hospital, Sweden.
Siv
S
Leijon
Ingrid
I
Bergh
Karin
K
Terstappen
D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D003668:Pressure Ulcer / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control*; D058996:Quality Improvement; D018570:Risk Assessment; D013548:Sweden / Q000453:epidemiology